Dima M. Qato

22.8k total citations · 3 hit papers
89 papers, 3.3k citations indexed

About

Dima M. Qato is a scholar working on Economics and Econometrics, Geriatrics and Gerontology and Family Practice. According to data from OpenAlex, Dima M. Qato has authored 89 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Economics and Econometrics, 27 papers in Geriatrics and Gerontology and 23 papers in Family Practice. Recurrent topics in Dima M. Qato's work include Pharmaceutical Practices and Patient Outcomes (27 papers), Medication Adherence and Compliance (23 papers) and Pharmaceutical Economics and Policy (20 papers). Dima M. Qato is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (27 papers), Medication Adherence and Compliance (23 papers) and Pharmaceutical Economics and Policy (20 papers). Dima M. Qato collaborates with scholars based in United States, New Zealand and Belgium. Dima M. Qato's co-authors include G. Caleb Alexander, L. Philip Schumm, Stacy Tessler Lindau, Jocelyn Wilder, Rena M. Conti, Michael Johnson, Randall S. Stafford, Jenny S. Guadamuz, Victoria Gillet and Omar Mansour and has published in prestigious journals such as The Lancet, JAMA and Circulation.

In The Last Decade

Dima M. Qato

83 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Use of Prescription and Over-the-counter Medications and Dietary Supplements Among Older Adults in the United States

2008 737 citations Dima M. Qato, G. Caleb Alexander et al. JAMA profile →
Changes in Prescription and Over-the-Counter Medication and Dietary Supplement Use Among Older Adults in the United States, 2005 vs 2011

2016 416 citations Dima M. Qato, Jocelyn Wilder et al. profile →
Use and Content of Primary Care Office-Based vs Telemedicine Care Visits During the COVID-19 Pandemic in the US

2020 313 citations G. Caleb Alexander, Dima M. Qato et al. profile →

Peers

Countries citing papers authored by Dima M. Qato

Since Specialization

Citations

This map shows the geographic impact of Dima M. Qato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dima M. Qato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dima M. Qato more than expected).

Fields of papers citing papers by Dima M. Qato

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dima M. Qato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dima M. Qato. The network helps show where Dima M. Qato may publish in the future.

Co-authorship network of co-authors of Dima M. Qato

This figure shows the co-authorship network connecting the top 25 collaborators of Dima M. Qato. A scholar is included among the top collaborators of Dima M. Qato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dima M. Qato. Dima M. Qato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Association Between Pharmacy Proximity With Cardiovascular Medication Use and Risk Factor Control in the United States 2024 ·Journal of the American Heart Association ·Alexander R. Zheutlin, Nasser Sharareh, Jenny S. Guadamuz, (unknown), Catherine G. Derington, Joshua A. Jacobs, (unknown), G. Caleb Alexander, Emily B. Levitan, Monika M. Safford, Robert O. Vos, Dima M. Qato, Adam P. Bress	1
2	Access to community pharmacies based on drive time and by rurality across the contiguous United States 2024 ·Journal of the American Pharmacists Association ·Nasser Sharareh, Alexander R. Zheutlin, Dima M. Qato, Jenny S. Guadamuz, Adam P. Bress, Robert O. Vos	7
3	More US Pharmacies Closed Than Opened In 2018–21; Independent Pharmacies, Those In Black, Latinx Communities Most At Risk 2024 ·Health Affairs ·Jenny S. Guadamuz, G. Caleb Alexander, Genevieve P. Kanter, Dima M. Qato	3
4	Pioneering Computational Culture Within Pharmacy Schools by Empowering Students With Data Science and Bioinformatics Skills 2024 ·American Journal of Pharmaceutical Education ·(unknown), (unknown), Nitesh Kumar Sharma, (unknown), Yesha Patel, Hovhannes J. Gukasyan, (unknown), (unknown), (unknown), (unknown), (unknown), William V. Padula, Daniel Tomaszewski, Tien M. H. Ng, Annie Wong‐Beringer, (unknown), Dima M. Qato, Daryl L. Davies, Vassilios Papadopoulos, Serghei Mangul	0
5	Citizenship status and cost‐related nonadherence in the United States, 2017–2021 2023 ·Health Services Research ·Jenny S. Guadamuz, Dima M. Qato	7
6	Adherence and persistence of HIV pre‐exposure prophylaxis use in the United States 2023 ·Pharmacoepidemiology and Drug Safety ·(unknown), Patrick S. Sullivan, Dima M. Qato, Stephanie Y. Crawford, Glen T. Schumock, Todd A. Lee	2
7	Adherence to HIV Pre-Exposure Prophylaxis Testing Guidelines in the United States 2023 ·AIDS Patient Care and STDs ·(unknown), Patrick S. Sullivan, Dima M. Qato, Stephanie Y. Crawford, Glen T. Schumock, Todd A. Lee	2
8	Changes in HIV Pre-exposure Prophylaxis (PrEP) Coverage at State and County Level During the COVID-19 Pandemic in the United States 2023 ·AIDS and Behavior ·(unknown), Jenny S. Guadamuz, (unknown), Dima M. Qato	6
9	Global, regional and national trends in statin utilisation in high-income and low/middle-income countries, 2015–2020 2022 ·BMJ Open ·Jenny S. Guadamuz, (unknown), Dima M. Qato	27
10	Trends in Medically Integrated Dispensing Among Oncology Practices 2022 ·JCO Oncology Practice ·Genevieve P. Kanter, Ravi B. Parikh, Michael Fisch, David Debono, Justin E. Bekelman, (unknown), (unknown), Gosia Sylwestrzak, John J. Barron, (unknown), Dima M. Qato, Mireille Jacobson	5
11	PRS36 Use of Logistic Lasso Regression to Predict Treatment Adherence Among Medicare Beneficiaries with COPD 2021 ·Value in Health ·Tham Le, Dima M. Qato, (unknown), Laurence S. Magder, Zafar Zafarí, Jane M. Simoni	1
12	Telepharmacy and Quality of Medication Use in Rural Areas, 2013–2019 2020 ·Preventing Chronic Disease ·Shweta Pathak, (unknown), Dima M. Qato, Benjamin Y. Urick	20
13	A Realistic Talking Human Embodied Agent Mobile Phone Intervention to Promote HIV Medication Adherence and Retention in Care in Young HIV-Positive African American Men Who Have Sex With Men: Qualitative Study 2018 ·JMIR mhealth and uhealth ·Mark S. Dworkin, Apurba Chakraborty, (unknown), Colleen Monahan, Lisa Hightow‐Weidman, Robert Garofalo, Dima M. Qato, Antonio D. Jimenez	29
14	Availability of Pharmacies Participating in the 340B Drug Pricing Program, 2016 2018 ·Value in Health ·Jenny S. Guadamuz, Dima M. Qato	1
15	The availability of pharmacies in the United States: 2007–2015 2017 ·PLoS ONE ·Dima M. Qato, Shannon N. Zenk, Jocelyn Wilder, Rachel Harrington, Darrell J. Gaskin, G. Caleb Alexander	144
16	The Availability Of Pharmacies And Pharmacy Services In The United States: 2007-2015 2016 ·Value in Health ·Dima M. Qato, Shannon N. Zenk, Jocelyn Wilder, Rachel Harrington, Darrell J. Gaskin, (unknown)	3
17	Effect of Direct-to-Consumer Advertising on Asthma Medication Sales and Healthcare Use 2015 ·American Journal of Respiratory and Critical Care Medicine ·Matthew Daubresse, Susan Hutfless, Yoonsang Kim, Rachel Kornfield, Dima M. Qato, Jidong Huang, Kay Miller, Sherry Emery, G. Caleb Alexander	24
18	Trends in Exposure to Televised Prescription Drug Advertising, 2003–2011 2015 ·American Journal of Preventive Medicine ·Rachel Kornfield, G. Caleb Alexander, Dima M. Qato, Yoonsang Kim, Jan D. Hirsch, Sherry Emery	13
19	Improving the Food and Drug Administration's Mandate to Ensure Postmarketing Drug Safety 2011 ·JAMA ·Dima M. Qato, G. Caleb Alexander	15
20	West Bank Barrier Decreases Access to Schools and Health Services 2007 ·Prehospital and Disaster Medicine ·Dima M. Qato, Shannon Doocy, (unknown), P. Gregg Greenough, Gilbert Burnham	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact